Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4875678
Max Phase: Preclinical
Molecular Formula: C18H19N5O9S2
Molecular Weight: 513.51
Molecule Type: Unknown
Associated Items:
ID: ALA4875678
Max Phase: Preclinical
Molecular Formula: C18H19N5O9S2
Molecular Weight: 513.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2[C@@H]1SC[C@@H]1CC(=O)O[C@@]12C(=O)O)c1csc(N)n1)C(=O)O
Standard InChI: InChI=1S/C18H19N5O9S2/c1-17(2,14(27)28)32-22-9(7-5-34-16(19)20-7)11(25)21-10-12(26)23-13(10)33-4-6-3-8(24)31-18(6,23)15(29)30/h5-6,10,13H,3-4H2,1-2H3,(H2,19,20)(H,21,25)(H,27,28)(H,29,30)/b22-9-/t6-,10+,13+,18+/m0/s1
Standard InChI Key: DLGMVQXWJRCHMV-BFAIENCSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 513.51 | Molecular Weight (Monoisotopic): 513.0624 | AlogP: -0.95 | #Rotatable Bonds: 7 |
Polar Surface Area: 210.81 | Molecular Species: ACID | HBA: 12 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.26 | CX Basic pKa: 3.92 | CX LogP: -0.75 | CX LogD: -6.25 |
Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.15 | Np Likeness Score: 0.45 |
1. Sato J, Kusano H, Aoki T, Shibuya S, Yokoo K, Komano K, Oguma T, Matsumoto S, Sato T, Yasuo K, Yamawaki K.. (2021) A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships., 46 [PMID:34450571] [10.1016/j.bmc.2021.116343] |
Source(1):